We previously found that the expression of PER1 in OSCC tissue was remarkably decreased and was significantly correlated with Tumor, Node, Metastasis clinical stage and that the 5-year survival rate of patients with low expression of PER1 was significantly reduced15,16. The gene discussed is PER1; the disease is neoplasm.